ClinicalTrials.Veeva

Menu

Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients

J

Johann Wolfgang Goethe University Hospital

Status

Unknown

Conditions

Allergy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

An increased number of patients with heparin-induced skin lesions is reported in the literature. Heparin-induced skin lesions may result from either occlusion of cutaneous vessels in patients suffering from autoimmune HIT or from a type IV allergic reaction (delayed type hypersensitivity (DTH) response). However, the incidence and nature of heparin-induced skin lesions has not been determined in a prospective investigation.

To address this open issue is the goal of this ongoing, so far monocenter, clinical investigation.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age > 18 Y.
  • s.c. anticoagulant therapy >6 days

Exclusion criteria

  • history of HIT
  • history of DTH to heparin

Trial design

500 participants in 1 patient group

s.c. anticoagulant therapy
Description:
All patients with s.c. anticoagulant therapy (UFH, LMWH, heparinoids, fondaparinux)

Trial contacts and locations

1

Loading...

Central trial contact

Ralf J Ludwig, MD; Wolf-Henning Boehncke, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems